JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M207835200 on August 27, 2002

J. Biol. Chem., Vol. 277, Issue 43, 41287-41293, October 25, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/43/41287    most recent
M207835200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edberg, J. C.
Right arrow Articles by Kimberly, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edberg, J. C.
Right arrow Articles by Kimberly, R. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The CY Domain of the Fcgamma RIa alpha -Chain (CD64) Alters gamma -Chain Tyrosine-based Signaling and Phagocytosis*

Jeffrey C. EdbergDagger §, Hongwei QinDagger §, Andrew W. GibsonDagger , Arthur M. F. Yee||, Patricia B. Redecha||, Zena K. Indik**, Alan D. Schreiber**, and Robert P. KimberlyDagger

From the Dagger  Departments of Medicine and Microbiology, The University of Alabama at Birmingham, Birmingham, Alabama 35294, || Department of Medicine, Hospital for Special Surgery and Weill Medical College of Cornell University, New York, New York 10021, and ** Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

Although the cytoplasmic domain of the human Fcgamma RIa alpha -chain lacks tyrosine-based phosphorylation motifs, it modulates receptor cycling and receptor-specific cytokine production. The cytoplasmic domain of Fcgamma RIa is constitutively phosphorylated, and the inhibition of dephosphorylation with okadaic acid, an inhibitor of type 1 and type 2A protein serine/threonine phosphatase, inhibits both receptor-induced activation of the early tyrosine phosphorylation cascade and receptor-specific phagocytosis. To explore the basis for these effects of the cytoplasmic domain of Fcgamma RIa, we developed a series of human Fcgamma RIa molecular variants, expressed in the murine macrophage cell line P388D1, and demonstrate that serine phosphorylation of the cytoplasmic domain is an important regulatory mechanism. Truncation of the cytoplasmic domain and mutation of the cytoplasmic domain serine residues to alanine abolish the okadaic acid inhibition of phagocytic function. In contrast, the serine mutants did not recapitulate the selective effects of cytoplasmic domain truncation on cytokine production. These results demonstrate for the first time a direct functional role for serine phosphorylation in the alpha -chain of Fcgamma RIa and suggest that the cytoplasmic domain of Fcgamma RI regulates the different functional capacities of the Fcgamma RIa-receptor complex.


* This work was supported by Grants RO1-AR33062, RO1-AR42476, and AI-22193 from the National Institutes of Health (NIH). Flow cytometry was supported in part by NIH Core Grant P60-AR20614 (to the University of Alabama at Birmingham).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

To whom correspondence should be addressed: University of Alabama at Birmingham, 1530 3rd Ave. S., THT433A, Birmingham, AL 35294-0006. Tel.: 205-934-0894; Fax: 205-934-1564; E-mail: JEdberg@uab.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Li, K. Su, C. Ji, A. J. Szalai, J. Wu, Y. Zhang, T. Zhou, R. P. Kimberly, and J. C. Edberg
Immune Opsonins Modulate BLyS/BAFF Release in a Receptor-Specific Fashion
J. Immunol., July 15, 2008; 181(2): 1012 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Qin, J. C. Edberg, A. W. Gibson, G. P. Page, L. Teng, and R. P. Kimberly
Differential Gene Expression Modulated by the Cytoplasmic Domain of Fc{gamma}RIa (CD64) {alpha}-Chain
J. Immunol., November 15, 2004; 173(10): 6211 - 6219.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Beekman, J. E. Bakema, J. van der Linden, B. Tops, M. Hinten, M. van Vugt, J. G. J. van de Winkel, and J. H. W. Leusen
Modulation of Fc{gamma}RI (CD64) Ligand Binding by Blocking Peptides of Periplakin
J. Biol. Chem., August 6, 2004; 279(32): 33875 - 33881.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Beekman, J. E. Bakema, J. G. J. van de Winkel, and J. H. W. Leusen
Direct interaction between Fc{gamma}RI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity
PNAS, July 13, 2004; 101(28): 10392 - 10397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.